Literature DB >> 6792756

Immunological and clinical features of smear-positive pulmonary tuberculosis in East Java.

T Kardjito, J M Grange.   

Abstract

The immunological and clinical features of 90 Javanese patients with smear -positive pulmonary tuberculosis were investigated. Many of the patients had advanced disease at the time of diagnosis and haemoptysis was common, especially in patients with cavitating lesions. Most patients had a significant elevation of one or more non-specific indicators of inflammation (erythrocyte sedimentation rate, third complement component, factor B and C-reactive protein). Rheumatoid factor was detected in 21% of the patients and was significantly associated with high levels of antibodies to M. tuberculosis in the IgM class. Five distinct responses were elicited by tuberculin testing; the most marked occurred at 24 hours. The degree of reaction at 6-8 hours correlated significantly with the levels of specific antibodies in the IgG and IgA classes and the 48 hour response correlated, although less markedly, with specific antibodies in the IgG class. Neither the degree of skin test reactivity nor the level of specific antimycobacterial antibodies correlated with the extent of disease as assessed radiologically. Nine per cent of the patients were skin-test negative at 48 hours but did not differ clinically, as a group, from tuberculin positive patients. It was not possible to place the cases in a spectrum of immunological responses similar to that occurring in leprosy and it is postulated that this is due to differences in the relevance to protection of the various immunological mechanisms in the two diseases. The need to establish more rigorous criteria for assessing the immune responses in tuberculosis and for studying the interactions between the protective and non-protective reactions is stressed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6792756     DOI: 10.1016/0041-3879(80)90043-4

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  10 in total

1.  Enzyme immunoassay using BCG in serodiagnosis of pulmonary tuberculosis.

Authors:  F L Garcia-Carreño; R E Carvajal; R Hernandez
Journal:  J Hyg (Lond)       Date:  1986-12

2.  Comparative evaluation of the diagnostic significance of circulating immune complexes and antibodies to phosphatidylinositomannosides in pulmonary tuberculosis by enzyme-linked immunosorbent assay.

Authors:  P K Mehta; G K Khuller
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

3.  Improved serodiagnosis of tuberculosis using two assay test.

Authors:  E Krambovitis; M Harris; D T Hughes
Journal:  J Clin Pathol       Date:  1986-07       Impact factor: 3.411

Review 4.  Immunopathogenesis in tuberculosis. Part II: Humoral mechanism of resistance.

Authors:  V Seth; U Singh
Journal:  Indian J Pediatr       Date:  1987 Nov-Dec       Impact factor: 1.967

5.  Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment.

Authors:  M Pai; R Joshi; M Bandyopadhyay; P Narang; S Dogra; B Taksande; S Kalantri
Journal:  Infection       Date:  2007-04       Impact factor: 3.553

6.  Histometric study of the localisation of lymphocyte subsets and accessory cells in human Mantoux reactions.

Authors:  J H Gibbs; J Ferguson; R A Brown; K J Kenicer; R C Potts; G Coghill; J Swanson Beck
Journal:  J Clin Pathol       Date:  1984-11       Impact factor: 3.411

7.  Role of repetitive antigen patterns for induction of antibodies against antibodies.

Authors:  T Fehr; M F Bachmann; E Bucher; U Kalinke; F E Di Padova; A B Lang; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  1997-05-19       Impact factor: 14.307

8.  Diagnostic delay and associated factors among patients with pulmonary tuberculosis in Dar es Salaam, Tanzania.

Authors:  Khadija Said; Jerry Hella; Grace Mhalu; Mary Chiryankubi; Edward Masika; Thomas Maroa; Francis Mhimbira; Neema Kapalata; Lukas Fenner
Journal:  Infect Dis Poverty       Date:  2017-03-24       Impact factor: 4.520

Review 9.  Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis.

Authors:  A Glatman-Freedman; A Casadevall
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

10.  Mycobacteria and the skin.

Authors:  J M Grange
Journal:  Int J Dermatol       Date:  1982-11       Impact factor: 2.736

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.